Medication reference
Vasopressin
Monograph awaiting updateThis monograph will be updated in the future.
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Vasopressin - Pitressin ® (opens in a new tab)Original source URL: https://globalrph.com/dilution/vasopressin-pitressin/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/vasopressin-pitressin/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:50:19.087698+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- b3cb2cf1b6aa96eea18232909cf65a5e8e4c72e00fdc3ae894930606da1c62ad
- Original response SHA-256
- 72c50fc0a19e3ef38b438a1cbfcb670749262f00bd07e8ac948c6c63f5723b83
- Source body SHA-256
- 137bf4ebdce9ebe72fbfcf2f265632a92a252281fdf4e97619ddb981f22ec2b8
Vasopressin (Pitressin ®) |
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. |
Usual Diluents |
| NS, D5W |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
| Acceptable concentration: (0.1 - 1.0 u/ ml) [100 units] [100 to 500 ml] [200 units] [250 ml] Infusion rate: as directed ICU - Vasodilatory shock/septic shock |
Stability / Miscellaneous |
| Stability: Trissels: No drug-solution combinations have been tested. [2010]
"Antidiuretic hormone" Dosing (adults): Vasodilatory shock/septic shock: Vasopressin may be used in patients with refractory shock despite adequate fluid resuscitation and the use of high-dose conventional catecholamines such as norepinephrine and dopamine, however, further studies are needed to determine its exact place in therapy. Current evidence does not support the use of vasopressin as a replacement for norepinephrine or dopamine as a first-line agent. The recommended infusion rate for vasopressin in the treatment of shock in adults is 0.01- 0.03 units/min. This dosage range is reported to be effective in about 85% of patients with norepinephrine resistant hypotension. Doses greater than 0.04 units/min may lead to cardiac arrest. Bleeding esophageal varices and other types of upper GI bleeds: MOA: ADH and pressor activity. Portal blood pressure is significantly decreased. A decrease in porto-systemic collateral flow and an increase in the muscular tone of the lower esophagus reduces blood flow to esophageal varices. The smooth muscle of the GI tract is also effected by large doses and peristaltic activity of the bowel and smooth muscles of the uterus are stimulated. INDICATIONS DOSAGE AND ADMINISTRATION Ten units of vasopressin (0.5mL) will usually elicit full physiologic response in adult patients: 5units will be adequate in many cases. Vasopressin should be given intramuscularly at three-or four-hour intervals as needed. The dosage should be proportionately reduced for children.(For an additional discussion of dosage, consult the sections below.) When determining the dose of vasopressin for a given case, the following should be kept in mind. It is particularly desirable to give a dose not much larger than is just sufficient to elicit the desired physiologic response. Excessive doses may cause undesirable side effects - blanching of the skin, abdominal cramps, nausea, which, though not serious, may be alarming to the patient. Spontaneous recovery from such side effects occurs in a few minutes. It has been found that one or two glasses of water given at the time vasopressin is administered reduce such symptoms. Abdominal Distention: In the average postoperative adult patient, give 5 units (0.25 mL) initially, increase to 10 units (0.5mL) at subsequent injections if necessary. It is recommended that vasopressin be given intramuscularly and that injections be repeated at three-or four-hour intervals as required. Dosage to be reduced proportionately for children. Vasopressin used in this manner will frequently prevent or relieve postoperative distension. These recommendations apply also to distention complicating pneumonia or other acute toxemias. Abdominal Roentgenography: For the average case, two injections of 10 units each (0.5 mL) are suggested . These should be given two hours and one-half hour, respectively, before films are exposed. Many roentgenologists advise giving an enema prior to the first dose of vasopressin. Diabetes Insipidus: Vasopressin may be given by injection or administered intranasally on cotton pledgets, by nasal spray, or by dropper. The dose by injection is 5 to 10 units (0.25 to 0.5mL) repeated two or three times daily as needed. When vasopressin is administered intranasally by spray or on pledgets, the dosage and interval between treatments must be determined for each patient. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to use, whenever solution and container permit. HOW SUPPLIED For intramuscular or subcutaneous use: 10 units per 0.5 mL multiple dose vial Boxes of 25 Store at controlled room temperature 15°-30° C (59°-86° F). Source: [package insert] |
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- no_routine_adjustment_identified
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- vasopressin
Source ID
H51-380EE1528268766573D5D1D6 - Generic name
- Vasopressin
Source ID
H51-5CFC6F6CAAD86E99087CCB85 - Class
- Cardiovascular and vasoactive
Source ID
H51-B0BC4FF72E24C11883B1E462 - Subclass
- Vasopressin receptor agonist
Source ID
H51-F0CADFE54AB210D05F7354E1 - Primary uses
- Vasodilatory shock
Source ID
H51-0875F1126AF86637CD369DCD - Selected vasoplegia and bleeding protocols
Source ID
H51-83E050BFE535ECF049E0AE30
- Vasodilatory shock
- Mechanism
- Activates vascular V1 and renal V2 receptors, producing vasoconstriction and water reabsorption.
Source ID
H51-1E111492EBCBE3CF7AE4518E - Mechanism level
- drug_specific
Source ID
H51-34DAC26CB8EE9F4C1DC73100 - Basic dosing orientation
- Adult septic shock infusion | Existing preparation record; use current package insert for indication-specific selection | Common bag 20 units | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric and neonatal infusion | Existing preparation record; use current package insert for indication-specific selection | Weight-based protocol | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion
Source ID
H51-65FDC08A4549D8BEAA18A47F - Administration orientation
- Common fixed rate 0.03 unit/min; Titrate or fixed rate per indication-specific protocol; 20 units/100 mL (0.2 unit/mL); 0.03 unit/min commonly; Often fixed rather than titrated; follow local shock protocol
Source ID
H51-5E02C706B9A5364FD775139B - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context.
Source ID
H51-D1A5FCA936421F5407018FAC - Key safety orientation
- Digital, mesenteric, cardiac, and skin ischemia.
Source ID
H51-76CC53255019A4C6C2BCDB48 - Hyponatremia can occur.
Source ID
H51-4992ECEE8CAD216847A77AD0 - Units/min and units/hour errors are dangerous.
Source ID
H51-D475572FE4F34E3B92DA1613
- Digital, mesenteric, cardiac, and skin ischemia.
- Coverage path
- structured_local_snapshot
Source ID
H51-DD624643CAED2254A188A791 - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-B93784ACE3FECCCDB1D0BFF4 - Legacy title
- Vasopressin
Source ID
H51-6C516B977EF183332BD95053 - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-9D7FF592AB1887658C4674E8 - Search text
- Vasopressin Cardiovascular and vasoactive Vasopressin receptor agonist Vasodilatory shock Selected vasoplegia and bleeding protocols Activates vascular V1 and renal V2 receptors, producing vasoconstriction and water reabsorption. Adult septic shock infusion | Existing preparation record; use current package insert for indication-specific selection | Common bag 20 units | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric and neonatal infusion | Existing preparation record; use current package insert for indication-specific selection | Weight-based protocol | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion Common fixed rate 0.03 unit/min; Titrate or fixed rate per indication-specific protocol; 20 units/100 mL (0.2 unit/mL); 0.03 unit/min commonly; Often fixed rather than titrated; follow local shock protocol No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context. Digital, mesenteric, cardiac, and skin ischemia. Hyponatremia can occur. Units/min and units/hour errors are dangerous. Structured GlobalRPh route snapshot
Source ID
H51-2FBF341047D4A3C7AAAF9AE4 - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Vasopressin (opens in a new tab)
Source ID
H51-BDC505BBF541CA0309017D69 - Official access mode
- search
Source ID
H51-C6DE719B9902CE0A93EFD146 - Official access url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Vasopressin (opens in a new tab)
Source ID
H51-31BD59D463A371EE14DDEA19 - Official search query
- Vasopressin
Source ID
H51-5AECCE55747F664F68079C99 - Official access reason
- A source-backed DailyMed search is available; select and confirm the exact IV product.
Source ID
H51-31635B2C157347DBEB80CBCB
No separate structured rows were bundled for IV push, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical dilution and intermittent infusion preparation
Recovered v5.1 source content; historical, awaiting current review.
| Population | Amount | Reconstitution | Diluent | Final volume | Concentration | Rate | Stability | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-8F87815B272899218CE6D087Source IDH51-3D8EC35D9F4B4D3010AB5D19 | Common bag 20 unitsSource IDH51-E52EAB0B942098245A981658 | Dilute vial or use premix.Source IDH51-27C8D01645AD1D1A4B98BCDE | NS or D5WSource IDH51-E0874F430E64E241371279C9 | 100 mLSource IDH51-CB37001990A6AF139E8CCEAD | 0.2 unit/mLSource IDH51-6358E37A49026F22EAF552C6 | Common fixed rate 0.03 unit/minSource IDH51-5315F14F5B11CF3E53444B10 | Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.Source IDH51-679DF8714AE70071A859903B | Do not extrapolate shock dosing to variceal bleeding or other indications.Source IDH51-04B84FC21C0E50D66F4499E5 |
Source IDH51-71BC2188A660925F3B932E49Source IDH51-7EF1599594CC48AB287E4696 | Weight-based protocolSource IDH51-A179F98797F122C43A29B95E | Pharmacy-prepared standardized concentration.Source IDH51-1DF11664FF4B293022E017E7 | Compatible fluidSource IDH51-EF5B103D1A1100BB5A18EF6E | Weight-appropriate volumeSource IDH51-AF0FF22C015116C574BDEAD3 | Institution-specificSource IDH51-011BAF2AEB94DF0C07A7A3EF | Titrate or fixed rate per indication-specific protocolSource IDH51-FEC09219C7048EC3222A888C | Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.Source IDH51-CE0C6C0881B86B7B9C94EDD5 |
Historical continuous-infusion guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Standard concentration | Initial rate | Titration | Maximum | Notes |
|---|---|---|---|---|---|
Source IDH51-599D3E7EC6D93D8A49F442E6Source IDH51-6C412FE8E5A27B96A46E596A | 20 units/100 mL (0.2 unit/mL)Source IDH51-5589F16B01187B49FD39CF0A | 0.03 unit/min commonlySource IDH51-F81E8500AE648DD8F3EA56AF | Often fixed rather than titrated; follow local shock protocolSource IDH51-C1E12750548938499D953695 | Commonly 0.04 unit/min in shock protocolsSource IDH51-1A1BB90DADC299D40189A686 | Higher doses increase ischemic risk and require explicit authorization.Source IDH51-09BF97BC4975CA3DA637ACBA |
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-8D9194CF36140A96EABA7B0ASource IDH51-43A3FF06BDD7B225088C59D1 | Adult septic shock infusionSource IDH51-529A2C032E485F1535C5A49A | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-0639425B53531B68E9BF7742 | Common bag 20 unitsSource IDH51-3334F138C4439404A1B7D38B | Not normalized in the preparation recordSource IDH51-493AB528BA0367515DAB666B | See current package insert and professional guidanceSource IDH51-A142C45539B46827767F69B0 | Common fixed rate 0.03 unit/minSource IDH51-D8FA0ED7A4AAA1164CF7D5B4 | Existing GlobalRPh structured preparation snapshotSource IDH51-2437E9EF66532F24BBC69C8F | Do not extrapolate shock dosing to variceal bleeding or other indications.Source IDH51-F0A73D346CAB6B0F1050A283 |
Source IDH51-76D35FC5190376DF7AEA8033Source IDH51-E639EAA007A96140C730E7F8 | Pediatric and neonatal infusionSource IDH51-19B29C528D55F3228C46CA82 | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-D983480CE0C15AFE25F84096 | Weight-based protocolSource IDH51-B75840327126F4510990E064 | Not normalized in the preparation recordSource IDH51-632FC394C82A98666F77F3E4 | See current package insert and professional guidanceSource IDH51-273328EC7281385767A433C8 | Titrate or fixed rate per indication-specific protocolSource IDH51-41EA86F535F4FA7F5EBEA23C | Existing GlobalRPh structured preparation snapshotSource IDH51-7D1CA5C2B00DA6EDEAA0D1AE | |
Source IDH51-CE12BD59697D4889CB5F1D46Source IDH51-8A46714D2B6AB537FECF39A3 | Adult septic shockSource IDH51-859E51EC8022D7BA338525F4 | Existing continuous-infusion recordSource IDH51-1846916BD5A6687707800179 | 0.03 unit/min commonlySource IDH51-8AE642274A60AC2120B1F9B7 | Continuous infusion; titration-specificSource IDH51-7AE4DAF9ABFBE69926AEF0F4 | Clinical-response dependentSource IDH51-220B7C80F355E8039E10D60D | Often fixed rather than titrated; follow local shock protocolSource IDH51-6EA7410B6F31DCEF61069527 | Existing GlobalRPh continuous-infusion snapshotSource IDH51-D378C00E30F10F6CD8F9E037 | Commonly 0.04 unit/min in shock protocols Higher doses increase ischemic risk and require explicit authorization.Source IDH51-D739616FDCED51596F2FAE7F |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- no_routine_adjustment_identified
Source ID
H51-61335D390115D6D487C96ECD - Summary
- No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context.
Source ID
H51-749CA8C9A2EDC0D692D527AD - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-08D463AF1900879AB53927ED
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Vasodilatory shock
Source ID
H51-3107A173A52FD75E3DAB6C3A - Selected vasoplegia and bleeding protocols
Source ID
H51-8A443FD7B0C533323E33A423
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Digital, mesenteric, cardiac, and skin ischemia.
Source ID
H51-3DDE505FCC560D2F6749BB9B - Hyponatremia can occur.
Source ID
H51-454115018F2D2A38371B8B84 - Units/min and units/hour errors are dangerous.
Source ID
H51-4BC7FFD537E2F242D24DA64D
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
- Blood pressure and perfusion
Source ID
H51-CA8ABDEB3FCEBBF4E26A6576 - Serum sodium
Source ID
H51-F84CD59D5E07EDE9D91FAD3C - Cardiac and peripheral ischemia
Source ID
H51-588C4294C797684A51A77840
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
vasopressinSource ID
H51-CD8AF9E8778288718B5FC435Generic name
VasopressinSource ID
H51-D2F4FF330F7BC6D5BF25C2FBBrand names
- Vasostrict
Source ID
H51-1DBB98C254EF3B5208B36993 - Pitressin
Source ID
H51-127B81CD3FB8DF9E45CF0A2C
Class
Cardiovascular and vasoactiveSource ID
H51-9EABF5AB059E40DB6482F56BSubclass
Vasopressin receptor agonistSource ID
H51-4C8E03117E46F908605B0314Summary
High-alert vasopressor commonly used as a fixed-dose adjunct in vasodilatory shock; other indications use different concentrations and regimens.Source ID
H51-6D68F5FCD576A50F222A9BC7Populations
- Adult
Source ID
H51-28D15E024FBB842B5E91327D - Pediatric
Source ID
H51-9E8C9F19189B54279BC4B50A - Neonatal
Source ID
H51-FADBDE70A8AA86793CABFA1E
Evidence tier
Core reference - verify current labelSource ID
H51-49E06DC43B9BF2DBB6F37C96High alert
trueSource ID
H51-99645610A740E38CB26DD954Hazardous
falseSource ID
H51-EA58B7C8DA273D32AB6C22B6Status
ActiveSource ID
H51-DCC24CAB760F355F41BA121AReviewed
2026-08-29Source ID
H51-CE2AFC0746945F4A90AC66A1Version added
1.0Source ID
H51-55C93E42BC9B5F0F04BDAED2Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-2F1AE91F3191A6AA8889F501Source IDH51-B48120EFF9270AB074592496 | https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vasopressin (opens in a new tab)Source IDH51-1B971CFA47CD54F367FA4499 | PrimarySource IDH51-4C7AD191E35471B6C315519F |
Source IDH51-C573A7F95DAA9D782E2FDCB7Source IDH51-B9CC9BBFD5C82C6569D4D33B | legacy:autoSource IDH51-AC72F5198706B31ADFA98D51 | LegacySource IDH51-2E4BEAB5C7844F407A6B1447 |
Legacy title
VasopressinSource ID
H51-D0088CD796879996FFF30DC0Clinical release verification
- Audit version
- 3.4
Source ID
H51-7897F8A610602073B3CD489A - Audited on
- 2026-08-30
Source ID
H51-7A1CEC989B8ADF0566667562 - Level
- amber
Source ID
H51-88F2F475EF8E02716DFB7D61 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-B23FD3B7279EBF367EA478E9 - Exact current label candidate
- false
Source ID
H51-E4D79970181CBAB0D8966177 - Numeric support ratio
- 0
Source ID
H51-D1179173AB5705A00F0A05EF - Reference url count
- 1
Source ID
H51-156A1E2A8109EB501E21A7CD - Broken reference count
- 0
Source ID
H51-3F72369F75BEBD7910266F43 - Point of use confirmation required
- true
Source ID
H51-06C45612389428F231AB73CA - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-D510D299915DB1712BEC41FD - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vasopressin (opens in a new tab)
Source ID
H51-620FE0A3FB3EC15BD7396AAC
Dosing source fields
Id
vasopressinSource ID
H51-4625457D4F15E339CE47EC3DGeneric name
VasopressinSource ID
H51-91006C916F712484E73EFBC2Coverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-68784C56B80066F9C1750DC1Package insert
- Query name
- Vasopressin
Source ID
H51-681CCBA5EF3CA84B329ACCA9 - Product and route must match
- true
Source ID
H51-562ED03EE9AC8E3B8BAAF663 - Live current label enabled
- false
Source ID
H51-69C2485CE46D5FD41947C671 - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-DEE05BA07DA1118196718566 - Direct official label access enabled
- true
Source ID
H51-2488A509F3A9A12138BD9D84 - Outbound server request required
- false
Source ID
H51-9D4FA76F81178CAA9D59615B - Local summary status
- not_bundled
Source ID
H51-8E694F4C4D7F074FE27F09DB
Clinical review
- Locally normalized
- false
Source ID
H51-0DF34B26976FFDDC9DAFD8EC - Reviewed
- 2026-08-29
Source ID
H51-B32FD40DFD93902E436C4F80 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-0444D7B487EDEB0DDBB04DCF
Clinical release verification
- Audit version
- 3.4
Source ID
H51-EE1D0BA2EACDA087CDD26D1B - Audited on
- 2026-08-30
Source ID
H51-BE363FFCCE022A0EA6B238A9 - Level
- amber
Source ID
H51-A95478E853A2012B9DCED44C - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-141E01C192C7BBEC06EA032A - Exact current label candidate
- false
Source ID
H51-DC929153FA2D1D2F4E382270 - Numeric support ratio
- 0
Source ID
H51-B205960E84A1DEE876A5A03E - Reference url count
- 1
Source ID
H51-FDD95608C217D384F8AE6014 - Broken reference count
- 0
Source ID
H51-8EBD8B797240213B32F0AABB - Point of use confirmation required
- true
Source ID
H51-BB4E00A3C0895691E16BDE7E - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-B762D1577885C953AF50A6EC - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vasopressin (opens in a new tab)
Source ID
H51-D4FA5089DD3D5FD282FA5C25
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- vasopressin
Source ID
H51-C0CDB9A172FFB2CD96F126DA - Name
- Vasopressin
Source ID
H51-78465972600E61AA812AEB16 - Brands
- Vasostrict | Pitressin
Source ID
H51-6DAA946414FBA0C6A33B3052 - Therapeutic class
- Cardiovascular and vasoactive
Source ID
H51-35F2C8DADD94D7C7EA51B2E5 - Review version
- 3.1
Source ID
H51-C591AA9CCD3E6B6038006D9D - Review date
- 2026-08-30
Source ID
H51-AF84246B41F7C12FCDA83DB3 - Release status
- structured_record_current_label_not_confirmed
Source ID
H51-B7C3966F6A5A620538BEF465 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-9968046722B980F8C8CF6032 - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-2B5EDCE4F3D5E3DDAA272B24
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-17D03BB03D8CFDFB3345D7A8 - Reconstitution concentration
- Dilute vial or use premix. Pharmacy-prepared standardized concentration.
Source ID
H51-89BD8E087CFA8DF8FCDDF1B9 - Maximum or recommended final concentration
- 20 units/100 mL (0.2 unit/mL)
Source ID
H51-88294FAEF96B3C8683E01327 - Appropriate standardized containers
- 100 mL Weight-appropriate volume
Source ID
H51-9BAB2DFAA587B3B8F54C4A79 - Adult dosing range
- Common bag 20 units Weight-based protocol 0.03 unit/min commonly
Source ID
H51-3EC60DFDD41BA2AF9CB56444 - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-A916CC6DFC06166E91CDA90B - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-D3DBB5C2618640432F903463 - Infusion time
- Common fixed rate 0.03 unit/min Titrate or fixed rate per indication-specific protocol 0.03 unit/min commonly
Source ID
H51-41AE5CB17B028B10B5A80411 - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-6FADE8DD092879EA7998B825 - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-E70E0173935AC25CD1668559 - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vasopressin (opens in a new tab)
Source ID
H51-B258B92D965F87EE90068847
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-4D6DAA93CAC5906840FAB69D
- Reconstitution concentration
- Primary
- existing_structured_record
Source ID
H51-D35A86B331E83911D83B23C0
- Maximum or recommended final concentration
- Primary
- existing_structured_record
Source ID
H51-565CBDC443FB5A3935E52198
- Appropriate standardized containers
- Primary
- existing_structured_record
Source ID
H51-8AF4B04600E99736E65515F5
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-8D67685162CF4D46546C3541
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-A78364576B8D770B6D391569
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-7C5CF50F13EF5F493D558D52
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-6335F8B757BA7EA045955B14
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-86D6CABD7FCD5503164C7879
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-3C4D813D1C1EEFF4FC34384B
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-8EFE649F80C54B75DDA1AA4C - Guide generation allowed
- true
Source ID
H51-C82CF2A5D612A9BC76C917A1
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-972EDC42628CDFF400160BAC - Guide generation allowed
- false
Source ID
H51-69903D9E4019A6DF9B22EDE5
- Neonatal
- Applicability
- supported_or_source_present
Source ID
H51-38F110E1E4EB1767A9C7CA15 - Guide generation allowed
- false
Source ID
H51-9694AC89C5F8F97CC858DB3E
- Route presence
- Structured dilution
- true
Source ID
H51-AC30DB367577C30FDAB6603D - Iv push
- false
Source ID
H51-1A0541A3200C01DFD1778966 - Continuous infusion
- true
Source ID
H51-3C58D68E9B7AC4E0894E349A - Pediatric source
- true
Source ID
H51-C9BFE2EC5B176A7C5A5F409E - Neonatal source
- true
Source ID
H51-85776A31D879591327A6B76E
- Legacy reference
- Status
- not_available
Source ID
H51-B1BE3AE5F94F2CE148BE774D
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-09F065DCB442CC66F7B96808
- Concentration values detected
High Unit Text 0.2Source ID
H51-64BEC000F141599AD14DC6F7Source ID
H51-74FAADD8D08EA26630428FD2unit Source ID
H51-09A14150611CA71AD1F6939B0.2 unit/mL Source ID
H51-F738FF37824D0F165C31981C- Source files
- catalog.json
Source ID
H51-AA0BDC42C6AEDA6BD5456593 - dosing.json
Source ID
H51-BA68C5D71084FA7CE8090091 - legacy-map.json
Source ID
H51-A83B14ED52818F3F3A7792D6
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-6EAA6D9FD01328C8435E0A28
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-CD8AF9E8778288718B5FC435 | catalog.json/records/248/id | Historical; current review incomplete |
H51-D2F4FF330F7BC6D5BF25C2FB | catalog.json/records/248/generic_name | Historical; current review incomplete |
H51-1DBB98C254EF3B5208B36993 | catalog.json/records/248/brand_names/0 | Historical; current review incomplete |
H51-127B81CD3FB8DF9E45CF0A2C | catalog.json/records/248/brand_names/1 | Historical; current review incomplete |
H51-9EABF5AB059E40DB6482F56B | catalog.json/records/248/class | Historical; current review incomplete |
H51-4C8E03117E46F908605B0314 | catalog.json/records/248/subclass | Historical; current review incomplete |
H51-6D68F5FCD576A50F222A9BC7 | catalog.json/records/248/summary | Historical; current review incomplete |
H51-3107A173A52FD75E3DAB6C3A | catalog.json/records/248/common_uses/0 | Historical; current review incomplete |
H51-8A443FD7B0C533323E33A423 | catalog.json/records/248/common_uses/1 | Historical; current review incomplete |
H51-8F87815B272899218CE6D087 | catalog.json/records/248/preparations/0 | Historical; current review incomplete |
H51-3D8EC35D9F4B4D3010AB5D19 | catalog.json/records/248/preparations/0/population | Historical; current review incomplete |
H51-E52EAB0B942098245A981658 | catalog.json/records/248/preparations/0/amount | Historical; current review incomplete |
H51-27C8D01645AD1D1A4B98BCDE | catalog.json/records/248/preparations/0/reconstitution | Historical; current review incomplete |
H51-E0874F430E64E241371279C9 | catalog.json/records/248/preparations/0/diluent | Historical; current review incomplete |
H51-CB37001990A6AF139E8CCEAD | catalog.json/records/248/preparations/0/final_volume | Historical; current review incomplete |
H51-6358E37A49026F22EAF552C6 | catalog.json/records/248/preparations/0/concentration | Historical; current review incomplete |
H51-5315F14F5B11CF3E53444B10 | catalog.json/records/248/preparations/0/rate | Historical; current review incomplete |
H51-679DF8714AE70071A859903B | catalog.json/records/248/preparations/0/stability | Historical; current review incomplete |
H51-04B84FC21C0E50D66F4499E5 | catalog.json/records/248/preparations/0/notes | Historical; current review incomplete |
H51-71BC2188A660925F3B932E49 | catalog.json/records/248/preparations/1 | Historical; current review incomplete |
H51-7EF1599594CC48AB287E4696 | catalog.json/records/248/preparations/1/population | Historical; current review incomplete |
H51-A179F98797F122C43A29B95E | catalog.json/records/248/preparations/1/amount | Historical; current review incomplete |
H51-1DF11664FF4B293022E017E7 | catalog.json/records/248/preparations/1/reconstitution | Historical; current review incomplete |
H51-EF5B103D1A1100BB5A18EF6E | catalog.json/records/248/preparations/1/diluent | Historical; current review incomplete |
H51-AF0FF22C015116C574BDEAD3 | catalog.json/records/248/preparations/1/final_volume | Historical; current review incomplete |
H51-011BAF2AEB94DF0C07A7A3EF | catalog.json/records/248/preparations/1/concentration | Historical; current review incomplete |
H51-FEC09219C7048EC3222A888C | catalog.json/records/248/preparations/1/rate | Historical; current review incomplete |
H51-CE0C6C0881B86B7B9C94EDD5 | catalog.json/records/248/preparations/1/stability | Historical; current review incomplete |
H51-8569720717D060A355C0886B | catalog.json/records/248/preparations/1/notes | Historical; current review incomplete |
H51-599D3E7EC6D93D8A49F442E6 | catalog.json/records/248/continuous_infusions/0 | Historical; current review incomplete |
H51-6C412FE8E5A27B96A46E596A | catalog.json/records/248/continuous_infusions/0/population | Historical; current review incomplete |
H51-5589F16B01187B49FD39CF0A | catalog.json/records/248/continuous_infusions/0/standard_concentration | Historical; current review incomplete |
H51-F81E8500AE648DD8F3EA56AF | catalog.json/records/248/continuous_infusions/0/initial_rate | Historical; current review incomplete |
H51-C1E12750548938499D953695 | catalog.json/records/248/continuous_infusions/0/titration | Historical; current review incomplete |
H51-1A1BB90DADC299D40189A686 | catalog.json/records/248/continuous_infusions/0/maximum | Historical; current review incomplete |
H51-09BF97BC4975CA3DA637ACBA | catalog.json/records/248/continuous_infusions/0/notes | Historical; current review incomplete |
H51-3DDE505FCC560D2F6749BB9B | catalog.json/records/248/warnings/0 | Historical; current review incomplete |
H51-454115018F2D2A38371B8B84 | catalog.json/records/248/warnings/1 | Historical; current review incomplete |
H51-4BC7FFD537E2F242D24DA64D | catalog.json/records/248/warnings/2 | Historical; current review incomplete |
H51-CA8ABDEB3FCEBBF4E26A6576 | catalog.json/records/248/monitoring/0 | Historical; current review incomplete |
H51-F84CD59D5E07EDE9D91FAD3C | catalog.json/records/248/monitoring/1 | Historical; current review incomplete |
H51-588C4294C797684A51A77840 | catalog.json/records/248/monitoring/2 | Historical; current review incomplete |
H51-28D15E024FBB842B5E91327D | catalog.json/records/248/populations/0 | Historical; current review incomplete |
H51-9E8C9F19189B54279BC4B50A | catalog.json/records/248/populations/1 | Historical; current review incomplete |
H51-FADBDE70A8AA86793CABFA1E | catalog.json/records/248/populations/2 | Historical; current review incomplete |
H51-49E06DC43B9BF2DBB6F37C96 | catalog.json/records/248/evidence_tier | Historical; current review incomplete |
H51-99645610A740E38CB26DD954 | catalog.json/records/248/high_alert | Historical; current review incomplete |
H51-EA58B7C8DA273D32AB6C22B6 | catalog.json/records/248/hazardous | Historical; current review incomplete |
H51-DCC24CAB760F355F41BA121A | catalog.json/records/248/status | Historical; current review incomplete |
H51-CE2AFC0746945F4A90AC66A1 | catalog.json/records/248/reviewed | Historical; current review incomplete |
H51-55C93E42BC9B5F0F04BDAED2 | catalog.json/records/248/version_added | Historical; current review incomplete |
H51-2F1AE91F3191A6AA8889F501 | catalog.json/records/248/sources/0 | Historical; current review incomplete |
H51-B48120EFF9270AB074592496 | catalog.json/records/248/sources/0/label | Historical; current review incomplete |
H51-1B971CFA47CD54F367FA4499 | catalog.json/records/248/sources/0/url | Historical; current review incomplete |
H51-4C7AD191E35471B6C315519F | catalog.json/records/248/sources/0/kind | Historical; current review incomplete |
H51-C573A7F95DAA9D782E2FDCB7 | catalog.json/records/248/sources/1 | Historical; current review incomplete |
H51-B9CC9BBFD5C82C6569D4D33B | catalog.json/records/248/sources/1/label | Historical; current review incomplete |
H51-AC72F5198706B31ADFA98D51 | catalog.json/records/248/sources/1/url | Historical; current review incomplete |
H51-2E4BEAB5C7844F407A6B1447 | catalog.json/records/248/sources/1/kind | Historical; current review incomplete |
H51-D0088CD796879996FFF30DC0 | catalog.json/records/248/legacy_title | Historical; current review incomplete |
H51-7897F8A610602073B3CD489A | catalog.json/records/248/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-7A1CEC989B8ADF0566667562 | catalog.json/records/248/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-88F2F475EF8E02716DFB7D61 | catalog.json/records/248/clinical_release_verification/level | Historical; current review incomplete |
H51-B23FD3B7279EBF367EA478E9 | catalog.json/records/248/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-E4D79970181CBAB0D8966177 | catalog.json/records/248/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-5485594C99CD09E77C3A8B77 | catalog.json/records/248/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-88E1A1699F937822A2404D35 | catalog.json/records/248/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-D1179173AB5705A00F0A05EF | catalog.json/records/248/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-156A1E2A8109EB501E21A7CD | catalog.json/records/248/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-3F72369F75BEBD7910266F43 | catalog.json/records/248/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-06C45612389428F231AB73CA | catalog.json/records/248/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-D510D299915DB1712BEC41FD | catalog.json/records/248/clinical_release_verification/note | Historical; current review incomplete |
H51-620FE0A3FB3EC15BD7396AAC | catalog.json/records/248/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-4625457D4F15E339CE47EC3D | dosing.json/records/248/id | Historical; current review incomplete |
H51-91006C916F712484E73EFBC2 | dosing.json/records/248/generic_name | Historical; current review incomplete |
H51-68784C56B80066F9C1750DC1 | dosing.json/records/248/coverage_status | Historical; current review incomplete |
H51-681CCBA5EF3CA84B329ACCA9 | dosing.json/records/248/package_insert/query_name | Historical; current review incomplete |
H51-E2D793F174A06BE134F42310 | dosing.json/records/248/package_insert/preferred_setid | Historical; current review incomplete |
H51-562ED03EE9AC8E3B8BAAF663 | dosing.json/records/248/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-69C2485CE46D5FD41947C671 | dosing.json/records/248/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-DEE05BA07DA1118196718566 | dosing.json/records/248/package_insert/source_priority | Historical; current review incomplete |
H51-2488A509F3A9A12138BD9D84 | dosing.json/records/248/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-9D4FA76F81178CAA9D59615B | dosing.json/records/248/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-8E694F4C4D7F074FE27F09DB | dosing.json/records/248/package_insert/local_summary_status | Historical; current review incomplete |
H51-61335D390115D6D487C96ECD | dosing.json/records/248/renal/classification | Historical; current review incomplete |
H51-749CA8C9A2EDC0D692D527AD | dosing.json/records/248/renal/summary | Historical; current review incomplete |
H51-08D463AF1900879AB53927ED | dosing.json/records/248/renal/method_note | Historical; current review incomplete |
H51-8D9194CF36140A96EABA7B0A | dosing.json/records/248/existing_route_snapshots/0 | Historical; current review incomplete |
H51-43A3FF06BDD7B225088C59D1 | dosing.json/records/248/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-529A2C032E485F1535C5A49A | dosing.json/records/248/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-0639425B53531B68E9BF7742 | dosing.json/records/248/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-3334F138C4439404A1B7D38B | dosing.json/records/248/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-493AB528BA0367515DAB666B | dosing.json/records/248/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-A142C45539B46827767F69B0 | dosing.json/records/248/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-D8FA0ED7A4AAA1164CF7D5B4 | dosing.json/records/248/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-2437E9EF66532F24BBC69C8F | dosing.json/records/248/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-F0A73D346CAB6B0F1050A283 | dosing.json/records/248/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-76D35FC5190376DF7AEA8033 | dosing.json/records/248/existing_route_snapshots/1 | Historical; current review incomplete |
H51-E639EAA007A96140C730E7F8 | dosing.json/records/248/existing_route_snapshots/1/route | Historical; current review incomplete |
H51-19B29C528D55F3228C46CA82 | dosing.json/records/248/existing_route_snapshots/1/population | Historical; current review incomplete |
H51-D983480CE0C15AFE25F84096 | dosing.json/records/248/existing_route_snapshots/1/indication | Historical; current review incomplete |
H51-B75840327126F4510990E064 | dosing.json/records/248/existing_route_snapshots/1/dose | Historical; current review incomplete |
H51-632FC394C82A98666F77F3E4 | dosing.json/records/248/existing_route_snapshots/1/interval | Historical; current review incomplete |
H51-273328EC7281385767A433C8 | dosing.json/records/248/existing_route_snapshots/1/duration | Historical; current review incomplete |
H51-41EA86F535F4FA7F5EBEA23C | dosing.json/records/248/existing_route_snapshots/1/administration | Historical; current review incomplete |
H51-7D1CA5C2B00DA6EDEAA0D1AE | dosing.json/records/248/existing_route_snapshots/1/source_level | Historical; current review incomplete |
H51-FAAD7879B6C70F20505C9A8D | dosing.json/records/248/existing_route_snapshots/1/notes | Historical; current review incomplete |
H51-CE12BD59697D4889CB5F1D46 | dosing.json/records/248/existing_route_snapshots/2 | Historical; current review incomplete |
H51-8A46714D2B6AB537FECF39A3 | dosing.json/records/248/existing_route_snapshots/2/route | Historical; current review incomplete |
H51-859E51EC8022D7BA338525F4 | dosing.json/records/248/existing_route_snapshots/2/population | Historical; current review incomplete |
H51-1846916BD5A6687707800179 | dosing.json/records/248/existing_route_snapshots/2/indication | Historical; current review incomplete |
H51-8AE642274A60AC2120B1F9B7 | dosing.json/records/248/existing_route_snapshots/2/dose | Historical; current review incomplete |
H51-7AE4DAF9ABFBE69926AEF0F4 | dosing.json/records/248/existing_route_snapshots/2/interval | Historical; current review incomplete |
H51-220B7C80F355E8039E10D60D | dosing.json/records/248/existing_route_snapshots/2/duration | Historical; current review incomplete |
H51-6EA7410B6F31DCEF61069527 | dosing.json/records/248/existing_route_snapshots/2/administration | Historical; current review incomplete |
H51-D378C00E30F10F6CD8F9E037 | dosing.json/records/248/existing_route_snapshots/2/source_level | Historical; current review incomplete |
H51-D739616FDCED51596F2FAE7F | dosing.json/records/248/existing_route_snapshots/2/notes | Historical; current review incomplete |
H51-0DF34B26976FFDDC9DAFD8EC | dosing.json/records/248/clinical_review/locally_normalized | Historical; current review incomplete |
H51-B32FD40DFD93902E436C4F80 | dosing.json/records/248/clinical_review/reviewed | Historical; current review incomplete |
H51-0444D7B487EDEB0DDBB04DCF | dosing.json/records/248/clinical_review/status | Historical; current review incomplete |
H51-EE1D0BA2EACDA087CDD26D1B | dosing.json/records/248/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-BE363FFCCE022A0EA6B238A9 | dosing.json/records/248/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-A95478E853A2012B9DCED44C | dosing.json/records/248/clinical_release_verification/level | Historical; current review incomplete |
H51-141E01C192C7BBEC06EA032A | dosing.json/records/248/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-DC929153FA2D1D2F4E382270 | dosing.json/records/248/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-8BF9B2C549D40E044DDA93CA | dosing.json/records/248/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-C27C13A667D1D0B5AEFFF66D | dosing.json/records/248/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-B205960E84A1DEE876A5A03E | dosing.json/records/248/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-FDD95608C217D384F8AE6014 | dosing.json/records/248/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-8EBD8B797240213B32F0AABB | dosing.json/records/248/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-BB4E00A3C0895691E16BDE7E | dosing.json/records/248/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-B762D1577885C953AF50A6EC | dosing.json/records/248/clinical_release_verification/note | Historical; current review incomplete |
H51-D4FA5089DD3D5FD282FA5C25 | dosing.json/records/248/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-380EE1528268766573D5D1D6 | first-look-v5.1.json/records/248/id | Historical; current review incomplete |
H51-5CFC6F6CAAD86E99087CCB85 | first-look-v5.1.json/records/248/generic_name | Historical; current review incomplete |
H51-B0BC4FF72E24C11883B1E462 | first-look-v5.1.json/records/248/class | Historical; current review incomplete |
H51-F0CADFE54AB210D05F7354E1 | first-look-v5.1.json/records/248/subclass | Historical; current review incomplete |
H51-0875F1126AF86637CD369DCD | first-look-v5.1.json/records/248/primary_uses/0 | Historical; current review incomplete |
H51-83E050BFE535ECF049E0AE30 | first-look-v5.1.json/records/248/primary_uses/1 | Historical; current review incomplete |
H51-1E111492EBCBE3CF7AE4518E | first-look-v5.1.json/records/248/mechanism | Historical; current review incomplete |
H51-34DAC26CB8EE9F4C1DC73100 | first-look-v5.1.json/records/248/mechanism_level | Historical; current review incomplete |
H51-65FDC08A4549D8BEAA18A47F | first-look-v5.1.json/records/248/basic_dosing_orientation | Historical; current review incomplete |
H51-5E02C706B9A5364FD775139B | first-look-v5.1.json/records/248/administration_orientation | Historical; current review incomplete |
H51-D1A5FCA936421F5407018FAC | first-look-v5.1.json/records/248/renal_and_population_orientation | Historical; current review incomplete |
H51-76CC53255019A4C6C2BCDB48 | first-look-v5.1.json/records/248/key_safety_orientation/0 | Historical; current review incomplete |
H51-4992ECEE8CAD216847A77AD0 | first-look-v5.1.json/records/248/key_safety_orientation/1 | Historical; current review incomplete |
H51-D475572FE4F34E3B92DA1613 | first-look-v5.1.json/records/248/key_safety_orientation/2 | Historical; current review incomplete |
H51-DD624643CAED2254A188A791 | first-look-v5.1.json/records/248/coverage_path | Historical; current review incomplete |
H51-B93784ACE3FECCCDB1D0BFF4 | first-look-v5.1.json/records/248/coverage_path_label | Historical; current review incomplete |
H51-064101D8CD590EB91DCA5A5F | first-look-v5.1.json/records/248/official_label_url | Historical; current review incomplete |
H51-6C516B977EF183332BD95053 | first-look-v5.1.json/records/248/legacy_title | Historical; current review incomplete |
H51-9D7FF592AB1887658C4674E8 | first-look-v5.1.json/records/248/review_note | Historical; current review incomplete |
H51-2FBF341047D4A3C7AAAF9AE4 | first-look-v5.1.json/records/248/search_text | Historical; current review incomplete |
H51-BDC505BBF541CA0309017D69 | first-look-v5.1.json/records/248/official_search_url | Historical; current review incomplete |
H51-C6DE719B9902CE0A93EFD146 | first-look-v5.1.json/records/248/official_access_mode | Historical; current review incomplete |
H51-31BD59D463A371EE14DDEA19 | first-look-v5.1.json/records/248/official_access_url | Historical; current review incomplete |
H51-5AECCE55747F664F68079C99 | first-look-v5.1.json/records/248/official_search_query | Historical; current review incomplete |
H51-31635B2C157347DBEB80CBCB | first-look-v5.1.json/records/248/official_access_reason | Historical; current review incomplete |
H51-C0CDB9A172FFB2CD96F126DA | preparation-assessments-v3.8.json/248/id | Historical; current review incomplete |
H51-78465972600E61AA812AEB16 | preparation-assessments-v3.8.json/248/name | Historical; current review incomplete |
H51-6DAA946414FBA0C6A33B3052 | preparation-assessments-v3.8.json/248/brands | Historical; current review incomplete |
H51-35F2C8DADD94D7C7EA51B2E5 | preparation-assessments-v3.8.json/248/therapeutic_class | Historical; current review incomplete |
H51-C591AA9CCD3E6B6038006D9D | preparation-assessments-v3.8.json/248/review_version | Historical; current review incomplete |
H51-AF84246B41F7C12FCDA83DB3 | preparation-assessments-v3.8.json/248/review_date | Historical; current review incomplete |
H51-B7C3966F6A5A620538BEF465 | preparation-assessments-v3.8.json/248/release_status | Historical; current review incomplete |
H51-9968046722B980F8C8CF6032 | preparation-assessments-v3.8.json/248/market_status/status | Historical; current review incomplete |
H51-2B5EDCE4F3D5E3DDAA272B24 | preparation-assessments-v3.8.json/248/market_status/basis | Historical; current review incomplete |
H51-17D03BB03D8CFDFB3345D7A8 | preparation-assessments-v3.8.json/248/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-89BD8E087CFA8DF8FCDDF1B9 | preparation-assessments-v3.8.json/248/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-88294FAEF96B3C8683E01327 | preparation-assessments-v3.8.json/248/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-9BAB2DFAA587B3B8F54C4A79 | preparation-assessments-v3.8.json/248/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-3EC60DFDD41BA2AF9CB56444 | preparation-assessments-v3.8.json/248/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-A916CC6DFC06166E91CDA90B | preparation-assessments-v3.8.json/248/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-D3DBB5C2618640432F903463 | preparation-assessments-v3.8.json/248/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-41AE5CB17B028B10B5A80411 | preparation-assessments-v3.8.json/248/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-6FADE8DD092879EA7998B825 | preparation-assessments-v3.8.json/248/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-9087A48A517AFEE4386896C3 | preparation-assessments-v3.8.json/248/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-77885060314E2702E1319DA4 | preparation-assessments-v3.8.json/248/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-6E83791EE3F713AF7E6DA892 | preparation-assessments-v3.8.json/248/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-7A0D03BEC91E43158CAC6B08 | preparation-assessments-v3.8.json/248/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-E70E0173935AC25CD1668559 | preparation-assessments-v3.8.json/248/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-B258B92D965F87EE90068847 | preparation-assessments-v3.8.json/248/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-4D6DAA93CAC5906840FAB69D | preparation-assessments-v3.8.json/248/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-D35A86B331E83911D83B23C0 | preparation-assessments-v3.8.json/248/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-565CBDC443FB5A3935E52198 | preparation-assessments-v3.8.json/248/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-8AF4B04600E99736E65515F5 | preparation-assessments-v3.8.json/248/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-8D67685162CF4D46546C3541 | preparation-assessments-v3.8.json/248/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-A78364576B8D770B6D391569 | preparation-assessments-v3.8.json/248/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-7C5CF50F13EF5F493D558D52 | preparation-assessments-v3.8.json/248/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-6335F8B757BA7EA045955B14 | preparation-assessments-v3.8.json/248/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-86D6CABD7FCD5503164C7879 | preparation-assessments-v3.8.json/248/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-3C4D813D1C1EEFF4FC34384B | preparation-assessments-v3.8.json/248/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-8EFE649F80C54B75DDA1AA4C | preparation-assessments-v3.8.json/248/population_applicability/adult/applicability | Historical; current review incomplete |
H51-C82CF2A5D612A9BC76C917A1 | preparation-assessments-v3.8.json/248/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-972EDC42628CDFF400160BAC | preparation-assessments-v3.8.json/248/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-69903D9E4019A6DF9B22EDE5 | preparation-assessments-v3.8.json/248/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-38F110E1E4EB1767A9C7CA15 | preparation-assessments-v3.8.json/248/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-9694AC89C5F8F97CC858DB3E | preparation-assessments-v3.8.json/248/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-AC30DB367577C30FDAB6603D | preparation-assessments-v3.8.json/248/route_presence/structured_dilution | Historical; current review incomplete |
H51-1A0541A3200C01DFD1778966 | preparation-assessments-v3.8.json/248/route_presence/iv_push | Historical; current review incomplete |
H51-3C58D68E9B7AC4E0894E349A | preparation-assessments-v3.8.json/248/route_presence/continuous_infusion | Historical; current review incomplete |
H51-C9BFE2EC5B176A7C5A5F409E | preparation-assessments-v3.8.json/248/route_presence/pediatric_source | Historical; current review incomplete |
H51-85776A31D879591327A6B76E | preparation-assessments-v3.8.json/248/route_presence/neonatal_source | Historical; current review incomplete |
H51-B1BE3AE5F94F2CE148BE774D | preparation-assessments-v3.8.json/248/legacy_reference/status | Historical; current review incomplete |
H51-09F065DCB442CC66F7B96808 | preparation-assessments-v3.8.json/248/label_resolution/status | Historical; current review incomplete |
H51-64BEC000F141599AD14DC6F7 | preparation-assessments-v3.8.json/248/concentration_values_detected/0 | Historical; current review incomplete |
H51-B331637562C091527277FCC5 | preparation-assessments-v3.8.json/248/concentration_values_detected/0/low | Historical; current review incomplete |
H51-74FAADD8D08EA26630428FD2 | preparation-assessments-v3.8.json/248/concentration_values_detected/0/high | Historical; current review incomplete |
H51-09A14150611CA71AD1F6939B | preparation-assessments-v3.8.json/248/concentration_values_detected/0/unit | Historical; current review incomplete |
H51-F738FF37824D0F165C31981C | preparation-assessments-v3.8.json/248/concentration_values_detected/0/text | Historical; current review incomplete |
H51-AA0BDC42C6AEDA6BD5456593 | preparation-assessments-v3.8.json/248/source_files/0 | Historical; current review incomplete |
H51-BA68C5D71084FA7CE8090091 | preparation-assessments-v3.8.json/248/source_files/1 | Historical; current review incomplete |
H51-A83B14ED52818F3F3A7792D6 | preparation-assessments-v3.8.json/248/source_files/2 | Historical; current review incomplete |
H51-6EAA6D9FD01328C8435E0A28 | preparation-assessments-v3.8.json/248/clinical_release_note | Historical; current review incomplete |
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)